Mainsail Asset Management »

Regeneron Pharmaceuticals shares owned by Mainsail Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Mainsail Asset Management from 13F filings

Historical chart of Mainsail Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Mainsail Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Mainsail Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $220k 285 771.87

More positions owned by Mainsail Asset Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Ultra Short Dur (ICSH)
Cintas Corporation (CTAS)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Apple (AAPL)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Dimensional Etf Trust Natl Mun Bd Etf (DFNM)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Inf Tech Etf (VGT)
Vanguard Whitehall Fds High Div Yld (VYM)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Mainsail Asset Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals